Skip to main content
RAPS Convergence 2023 Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Presentation Icons
Requires Pre-Registration or Sign-up
Requires Pre-Registration or Sign-up
Additional Registration Fee
Additional Registration Fee
Invitation Only
Invitation Only
Student Program
Student Program
Networking Opportunity
Networking Opportunity
RAPS Focus Area
RAPS Focus Area
Back

Nicholas Langevin

Director, Regulatory Affairs
Sumitomo Pharma America, Inc.

Nick Langevin, MS, PMP, RAC, is Director, Regulataory Affairs at Sumitomo Pharma America, Inc. (SMPA). At SMPA, Nick serves as a Global Regulatory Lead overseeing regulatory strategy for pharmaceutical products and tissue/cell therapies in all phases of development. Nick has more than 25 years experience in medical product development and is currently serving as SMPA's representative on PhRMA's Diversity and PFDD workgroups. Nick is passionate about inclusion of the patient voice in medical product development and has participated in multiple FDA public workshops on the PFDD guidance series.

Disclosure information not submitted.

Presentation(s):